 |
|
|
| |
Location preferences for accessing long-acting injectable pre-exposure prophylaxis (LA-PrEP) among men who have sex with men (MSM) in the U.S currently using daily-oral PrEP
|
| |
| |
AIDS 2024, the 25th International AIDS Conference
Jennifer L. Glick, PhD, MPH1,2; Danielle F. Nestadt PhD, MPH, MSW2; Travis Sanchez, DVM, MPH3, Kevin Li, MPH2; Marissa Hannah, MPH3; M Keith Rawlings, MD4; Supriya Sarkar, PhD, MPH4; Vani Vannappagari, PhD, MPH, MBBS4
1 Louisiana State University Health Science Center, School of Public Health, New Orleans, LA, USA ; 2 Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA; 3 Emory Rollins School of Public Health, Atlanta, Georgia, USA; 4 ViiV Healthcare, Durham, North Carolina, USA
|
| |
|
|
|
|
|
